Osmundsen K - Search Results

1

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

Pownall HJ, Brauchi D, Kilinç C, Osmundsen K, Pao Q, Payton-Ross C, Gotto AM Jr, Ballantyne CM. Pownall HJ, et al. Among authors: osmundsen k. Atherosclerosis. 1999 Apr;143(2):285-97. doi: 10.1016/s0021-9150(98)00301-3. Atherosclerosis. 1999. PMID: 10217357 Clinical Trial.

2

Alterations in serum phosphatidylcholine fatty acyl species by eicosapentaenoic and docosahexaenoic ethyl esters in patients with severe hypertriglyceridemia.

McKeone BJ, Osmundsen K, Brauchi D, Pao Q, Payton-Ross C, Kilinç C, Kummerow FA, Pownall HJ. McKeone BJ, et al. Among authors: osmundsen k. J Lipid Res. 1997 Mar;38(3):429-36. J Lipid Res. 1997. PMID: 9101424 Free article. Clinical Trial.

3

Soluble cell adhesion molecules in hypertriglyceridemia and potential significance on monocyte adhesion.

Abe Y, El-Masri B, Kimball KT, Pownall H, Reilly CF, Osmundsen K, Smith CW, Ballantyne CM. Abe Y, et al. Among authors: osmundsen k. Arterioscler Thromb Vasc Biol. 1998 May;18(5):723-31. doi: 10.1161/01.atv.18.5.723. Arterioscler Thromb Vasc Biol. 1998. PMID: 9598830

4

Safety and efficacy of Omacor in severe hypertriglyceridemia.

Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K. Harris WS, et al. Among authors: osmundsen k. J Cardiovasc Risk. 1997 Oct-Dec;4(5-6):385-91. J Cardiovasc Risk. 1997. PMID: 9865671 Clinical Trial.

5

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.

Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C. Westphal S, et al. Among authors: osmundsen k. Am J Clin Nutr. 2000 Apr;71(4):914-20. doi: 10.1093/ajcn/71.4.914. Am J Clin Nutr. 2000. PMID: 10731497

6

Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation.

Semb KA, Fodstad O, Klem B, Bibow K, Osmundsen K, Aamdal S. Semb KA, et al. Among authors: osmundsen k. Anticancer Drugs. 1997 Mar;8(3):296-303. doi: 10.1097/00001813-199703000-00013. Anticancer Drugs. 1997. PMID: 9095337 Clinical Trial.

7

Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanoma.

Semb KA, Aamdal S, Mette E, Ingvar C, Gullaksen N, Osmundsen K. Semb KA, et al. Among authors: osmundsen k. Anticancer Drugs. 1998 Oct;9(9):797-802. doi: 10.1097/00001813-199810000-00009. Anticancer Drugs. 1998. PMID: 9840726 Clinical Trial.

8

[Drug therapy of hyperlipidemia--unanswered questions].

Osmundsen K. Osmundsen K. Tidsskr Nor Laegeforen. 1997 Apr 10;117(9):1334. Tidsskr Nor Laegeforen. 1997. PMID: 9182369 Norwegian. No abstract available.

9

[Frequent cystitis in elderly women. A double-blind comparison of Hiprex and placebo in general practice].

Gundersen R, Høivik HO, Osmundsen K. Gundersen R, et al. Among authors: osmundsen k. Tidsskr Nor Laegeforen. 1986 Sep 10;106(25):2048-9. Tidsskr Nor Laegeforen. 1986. PMID: 3535165 Clinical Trial. Norwegian. No abstract available.

10

[Combined analgesics in myalgia of the neck. A double-blind comparison of paracetamol and orphenadrine (Norgesic) and paracetamol and codeine (Paralgin forte) in general practice].

Høivik HO, Gundersen R, Osmundsen K. Høivik HO, et al. Among authors: osmundsen k. Tidsskr Nor Laegeforen. 1986 Jan 20;106(2):126-8. Tidsskr Nor Laegeforen. 1986. PMID: 3513364 Clinical Trial. Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters